Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial.
Journal: Nature communications
Published: November 05, 2025
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial.
Journal: JAMA network open
Published: November 02, 2023
Phase I/II Study of Combined BCL-xL and MEK Inhibition with Navitoclax and Trametinib in KRAS or NRAS Mutant Advanced Solid Tumors.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 12, 2023
Investigation of selective glucocorticoid receptor modulation in high-grade serous ovarian cancer PDX models.
Journal: Journal of gynecologic oncology
Published: October 02, 2023
A plain language summary of results from the GARNET study of dostarlimab in patients with endometrial cancer.
Journal: Future oncology (London, England)
Published: June 29, 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 22, 2022
Addressing the diagnostic and therapeutic dilemmas of ovarian immature teratoma: Report from a clinicopathologic consensus conference.
Journal: European journal of cancer (Oxford, England : 1990)
Published: February 26, 2022
Safety and Efficacy of Dostarlimab in Patients With Recurrent/Advanced Non-small Cell Lung Cancer: Results from Cohort E of the Phase I GARNET Trial.
Journal: Clinical lung cancer
Published: February 02, 2022
Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET-a phase I, single-arm study.
Journal: Journal for immunotherapy of cancer
Published: December 13, 2021
Phase II Study of the WEE1 Inhibitor Adavosertib in Recurrent Uterine Serous Carcinoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 11, 2021
A serous borderline ovarian tumour in a transgender male adolescent.
Journal: British journal of cancer
Published: May 11, 2020
Contemporary management of ovarian germ cell tumors and remaining controversies.
Journal: Gynecologic oncology
Published: January 29, 2020
Last Updated: 09/26/2026